rs387906950
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000017.4(ACADS):āc.1031A>Gā(p.Glu344Gly) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000502 in 1,612,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_000017.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACADS | NM_000017.4 | c.1031A>G | p.Glu344Gly | missense_variant, splice_region_variant | 9/10 | ENST00000242592.9 | |
ACADS | NM_001302554.2 | c.1019A>G | p.Glu340Gly | missense_variant, splice_region_variant | 9/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACADS | ENST00000242592.9 | c.1031A>G | p.Glu344Gly | missense_variant, splice_region_variant | 9/10 | 1 | NM_000017.4 | P1 | |
ACADS | ENST00000411593.2 | c.1019A>G | p.Glu340Gly | missense_variant, splice_region_variant | 9/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152092Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000101 AC: 25AN: 247512Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134868
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1460762Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 726706
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74432
ClinVar
Submissions by phenotype
Deficiency of butyryl-CoA dehydrogenase Pathogenic:9
Pathogenic, no assertion criteria provided | clinical testing | Neonatal Disease Screening Center, Medical Genetics Center, Huaihua City Maternal and Child Health Care Hospital | - | PS3+PM3_VS+PP1+PP3+PP4 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2010 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 10, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 344 of the ACADS protein (p.Glu344Gly). This variant is present in population databases (rs387906950, gnomAD 0.1%). This missense change has been observed in individual(s) with SCAD deficiency (PMID: 18523805, 20376488, 21325261, 27466294, 27938594, 28532786, 29519241). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 30612). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ACADS function (PMID: 18523805, 20376488). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Apr 08, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 03, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 26, 2022 | - - |
ACADS-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2023 | The ACADS c.1031A>G variant is predicted to result in the amino acid substitution p.Glu344Gly. This variant was reported in individuals with short-chain acyl-CoA-dehydrogenase deficiency (see for example at Pedersen et al. 2008. PubMed ID: 18523805; Shirao et al. 2010. PubMed ID: 20376488; Kim et al. 2011. PubMed ID: 21325261; Huang et al. 2016. PubMed ID: 27938594). This variant is reported in 0.13% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-121176944-A-G). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at